CG
IMUX icon

Cutler Group’s Immunic IMUX Stock Holding History

Cutler Group’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13
Closed -$13K – 4228
2018
Q3 		$13K Buy
+13
New +$33.9K ﹤0.01% 2496
2018
Q1 		– Sell
-4
Closed -$12K – 4803
2017
Q4 		$12K Hold
4
– – ﹤0.01% 2981
2017
Q3 		$14K Hold
4
– – ﹤0.01% 3486
2017
Q2 		$17K Hold
4
– – ﹤0.01% 3581
2017
Q1 		$16K Hold
4
– – ﹤0.01% 3555
2016
Q4 		$17K Sell
4
-2
-33% -$4.38K ﹤0.01% 3631
2016
Q3 		$15K Sell
6
-4
-40% -$9.87K ﹤0.01% 3719
2016
Q2 		$31K Sell
10
-153
-94% -$503K ﹤0.01% 2866
2016
Q1 		$523K Buy
163
+127
+353% +$441K 0.03% 507
2015
Q4 		$90K Buy
+36
New +$117K 0.01% 1886

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Cutler Group's IMUX Position: Q1 2024 in Review

Cutler Group sold out of Immunic (IMUX) in Q1 2024, closing a stake of 140 shares — an estimated $2K sold.

Cutler Group first reported a position in IMUX in Q4 2015 and held it in 28 quarters. The position peaked at $109K in Q4 2015. 59 funds tracked by Wall St. Rank hold IMUX as of Q1 2024.

  • Cutler Group reported no remaining Immunic position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 140 Immunic shares in Q1 2024, an estimated $2K.
  • Cutler Group first reported a position in Immunic in Q4 2015 and held it in 28 quarters.
  • Cutler Group's Immunic position peaked at $109K in Q4 2015.
  • 59 funds tracked by Wall St. Rank held Immunic as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.